Franziska Gamma

460 total citations
30 papers, 299 citations indexed

About

Franziska Gamma is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Franziska Gamma has authored 30 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 6 papers in Physiology and 5 papers in Pharmacology. Recurrent topics in Franziska Gamma's work include Schizophrenia research and treatment (14 papers), Bipolar Disorder and Treatment (9 papers) and Genetic Associations and Epidemiology (5 papers). Franziska Gamma is often cited by papers focused on Schizophrenia research and treatment (14 papers), Bipolar Disorder and Treatment (9 papers) and Genetic Associations and Epidemiology (5 papers). Franziska Gamma collaborates with scholars based in Switzerland, United States and France. Franziska Gamma's co-authors include Stéphane Rothen, Martin Preisig, Caroline L. Vandeleur, Nicolas Jeanprêtre, Ming T. Tsuang, François Ferrero, Olivier Halfon, Chin B. Eap, Philippe Conus and Armin von Gunten and has published in prestigious journals such as Gene, Molecular Psychiatry and Personality and Individual Differences.

In The Last Decade

Franziska Gamma

23 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franziska Gamma Switzerland 10 152 110 41 41 40 30 299
Rosa Dueñas Spain 12 330 2.2× 170 1.5× 29 0.7× 74 1.8× 36 0.9× 21 525
Ayhan Algül Türkiye 11 156 1.0× 156 1.4× 23 0.6× 37 0.9× 61 1.5× 39 362
Manuel Canal‐Rivero Spain 14 236 1.6× 137 1.2× 12 0.3× 37 0.9× 32 0.8× 36 382
Licínia Ganança Portugal 8 155 1.0× 155 1.4× 31 0.8× 33 0.8× 40 1.0× 12 393
Anna M. Fineberg United States 7 117 0.8× 110 1.0× 111 2.7× 18 0.4× 26 0.7× 7 432
Seth D. Maxwell United States 10 123 0.8× 139 1.3× 124 3.0× 23 0.6× 41 1.0× 14 420
Barbara B. Barton Germany 9 150 1.0× 222 2.0× 17 0.4× 72 1.8× 51 1.3× 31 446
Agnieszka Gmitrowicz Poland 10 92 0.6× 123 1.1× 26 0.6× 30 0.7× 21 0.5× 55 383
Carlos Martín Spain 3 205 1.3× 107 1.0× 15 0.4× 21 0.5× 37 0.9× 5 365
Romain Icick France 12 147 1.0× 101 0.9× 24 0.6× 21 0.5× 44 1.1× 42 351

Countries citing papers authored by Franziska Gamma

Since Specialization
Citations

This map shows the geographic impact of Franziska Gamma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franziska Gamma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franziska Gamma more than expected).

Fields of papers citing papers by Franziska Gamma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franziska Gamma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franziska Gamma. The network helps show where Franziska Gamma may publish in the future.

Co-authorship network of co-authors of Franziska Gamma

This figure shows the co-authorship network connecting the top 25 collaborators of Franziska Gamma. A scholar is included among the top collaborators of Franziska Gamma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franziska Gamma. Franziska Gamma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eap, Chin B., et al.. (2025). CYP2D6 GENOTYPES AND TREATMENT FAILURE WITH RISPERIDONE OR ARIPIPRAZOLE: RESULTS FROM A ONE-YEAR LONGITUDINAL STUDY. The International Journal of Neuropsychopharmacology. 28(Supplement_1). i88–i89.
2.
Ranjbar, Setareh, François Girardin, Frederik Vandenberghe, et al.. (2025). Influence of C YP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to Aripiprazole. Schizophrenia Bulletin. 52(2).
3.
Ferrari, Marco, Giorgio Pistis, Franziska Gamma, et al.. (2024). Prediction of antipsychotics efficacy based on a polygenic risk score: a real-world cohort study. Frontiers in Pharmacology. 15. 1274442–1274442. 4 indexed citations
4.
Lin, Jue, Marie C. Sadler, Setareh Ranjbar, et al.. (2024). Psychotropic-induced weight gain and telomere length: results from a one-year longitudinal study and a large population-based cohort. Translational Psychiatry. 14(1). 471–471.
6.
Ranjbar, Setareh, Othman Sentissi, Mohamed Lakhal, et al.. (2024). Aripiprazole dose associations with metabolic adverse effect: Results from a longitudinal study. Schizophrenia Research. 270. 403–409. 2 indexed citations
8.
Sjaarda, Jennifer, Frederik Vandenberghe, Séverine Crettol, et al.. (2023). Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis. Molecular Psychiatry. 28(6). 2320–2327. 8 indexed citations
10.
Gamma, Franziska, Alessandra Solida, Kerstin Jessica Plessen, et al.. (2022). Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters. The Journal of Clinical Psychiatry. 83(4). 8 indexed citations
11.
Sjaarda, Jennifer, Nicolas Ansermot, Séverine Crettol, et al.. (2021). Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort. Frontiers in Psychiatry. 12. 756403–756403. 4 indexed citations
12.
Vandenberghe, Frederik, Lina Quteineh, Mehdi Gholam‐Rezaee, et al.. (2017). Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs. Gene. 628. 8–15. 5 indexed citations
13.
Rougemont-Bücking, Ansgar, Franziska Gamma, & Jaak Panksepp. (2017). Use of tramadol in psychiatric care: a comprehensive review and report of two cases. Swiss Medical Weekly. 147(1920). w14428–w14428. 15 indexed citations
14.
Gamma, Franziska, Jill M. Goldstein, Larry J. Seidman, et al.. (2013). Early Intermodal Integration in Offspring of Parents With Psychosis. Schizophrenia Bulletin. 40(5). 992–1000. 19 indexed citations
15.
Rothen, Stéphane, Caroline L. Vandeleur, Nicolas Jeanprêtre, et al.. (2009). Parent–child agreement and prevalence estimates of diagnoses in childhood: Direct interview versus family history method. International Journal of Methods in Psychiatric Research. 18(2). 96–109. 72 indexed citations
16.
Rothen, Stéphane, Caroline L. Vandeleur, Nicolas Jeanprêtre, et al.. (2008). Personality traits in children of parents with unipolar and bipolar mood disorders. Journal of Affective Disorders. 113(1-2). 133–141. 17 indexed citations
17.
Vandeleur, Caroline L., Stéphane Rothen, Nicolas Jeanprêtre, et al.. (2007). Inter-informant agreement and prevalence estimates for substance use disorders: Direct interview versus family history method. Drug and Alcohol Dependence. 92(1-3). 9–19. 27 indexed citations
18.
Gamma, Franziska, et al.. (2004). Meta-analysis shows schizophrenia is not associated with the 40-base-pair repeat polymorphism of the dopamine transporter gene. Schizophrenia Research. 73(1). 55–58. 30 indexed citations
19.
Tsuang, Ming T., William S. Stone, Franziska Gamma, & Stephen V. Faraone. (2003). Schizotaxia: Current status and future directions. Current Psychiatry Reports. 5(2). 128–134. 9 indexed citations
20.
Bovet, Pascal & Franziska Gamma. (2002). Vulnerability to schizophrenia: Relevance of patients' subjective experience for empirical and clinical work. American Journal of Medical Genetics. 114(8). 923–926. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026